Compare JAV to:
After Hours: 1.45 N/A (N/A) 8:47am ET
| Last Trade: | 1.47 |
|---|---|
| Trade Time: | 4:01pm ET |
| Change: | |
| Prev Close: | 1.45 |
| Open: | 1.48 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 3.17 |
| Day's Range: | 1.45 - 1.50 |
|---|---|
| 52wk Range: | 0.40 - 2.28 |
| Volume: | 234,433 |
| Avg Vol (3m): | 341,308 |
| Market Cap: | 93.88M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.72 |
| Div & Yield: | N/A (N/A) |
| Fri, Nov 13 | JAVELIN PHARMACEUTICALS, INC FinancialsEDGAR Online Financials |
| Wed, Nov 11 | New Star Analyst Rankings for JAVELIN PHARMACEUTICStarMine |
| Tue, Nov 10 | Piper Jaffray Award Winning Analyst Says Health Care Reform Equity Valuation Fears Have Passed: Stock Picks For Q4 2009Wall Street Transcript |
| Tue, Nov 10 | Javelin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcriptat Seeking Alpha |
| Tue, Nov 10 | JAVELIN PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online |
| Tue, Nov 10 | Q3 2009 JAVELIN PHARMACEUTICALS INC Earnings Release - Time Not SuppliedCCBN |
| Tue, Nov 10 | Javelin Pharmaceuticals, Inc. Reports Third Quarter 2009 ResultsBusiness Wire |
| Mon, Nov 9 | JAVELIN PHARMACEUTICALS, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Wed, Nov 4 | Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial ResultsBusiness Wire |
| Mon, Nov 2 | CEO Interview: Winston Pharmaceuticals, Inc. - Dr. Joel E. BernsteinWall Street Transcript |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.